Abstract
Introduction: Phospholipases are enzymes that occur in many types of human cells, including mast cells, and play an important role in the molecular background of asthma pathogenesis, and the development of inflammation NF-κB activities that affect numerous biological processes has been reported in many inflammatory diseases including asthma. Vitamin D is a widely studied factor that affects many diseases, including asthma. The aim of this study is to assess the influence of 1,25-(OH)2D3 on regulation of chosen phospholipase-A2 (PLA2) expression-selected inflammation mediators. Methods: LUVA mast cells were stimulated with 1,25(OH)2D3, and inhibitors of NF-κB p65 and ubiquitination. Expression analysis of phospholipases (PLA2G5, PLA2G10, PLA2G12, PLA2G15, PLA2G4A, PLA2G4B, PLA2G4C, PLAA, NF-κB p65, and UBC) was done utilizing real-time PCR and Western blot. Eicosanoid (LTC4, LXA4, 15[S]-HETE, and PGE2) levels and sPLA2 were also measured. Results: We found that 1,25(OH)2D3 decreased the expression of PLA2G5, PLA2G15, PLA2G5, UBC, and NF-κB p65 but increased expression of PLAA and PLA2G4C (p < 0.05). Moreover, the expression of PLA2G5 and PLA2G15 decreased after inhibition of NF-κB p65 and UBC. Increased levels of released LXA4 and 15(S)-HETE, decreased levels of LTC4, and sPLA2s enzymatic activity in response to 1,25(OH)2D3 were also observed. Additionally, NF-κB p65 inhibition led to an increase in the LXA4 concentration.Conclusion: Future investigations will be needed to further clarify the role of 1,25(OH)2D3 in the context of asthma and the inflammatory process; however, these results confirm a variety of effects which can be caused by this vitamin. 1,25(OH)2D3-mediated action may result in the development of new therapeutic strategies for asthma treatment.
References
1.
Carlberg
C
, Seuter
S
, Heikkinen
S
. The first genome-wide view of vitamin D receptor locations and their mechanistic implications
. Anticancer Res
. 2012
Jan
;32
(1
):271
–82
.
[PubMed]
1791-75302.
Huang
H
, Porpodis
K
, Zarogoulidis
P
, Domvri
K
, Giouleka
P
, Papaiwannou
A
, et al. Vitamin D in asthma and future perspectives
. Drug Des Devel Ther
. 2013
Sep
;7
:1003
–13
.
[PubMed]
1177-88813.
Paul
G
, Brehm
JM
, Alcorn
JF
, Holguín
F
, Aujla
SJ
, Celedón
JC
. Vitamin D and asthma
. Am J Respir Crit Care Med
. 2012
Jan
;185
(2
):124
–32
.
[PubMed]
1073-449X4.
Batmaz
SB
, Arıkoğlu
T
, Tamer
L
, Eskandari
G
, Kuyucu
S
. Seasonal variation of asthma control, lung function tests and allergic inflammation in relation to vitamin D levels: a prospective annual study
. Postepy Dermatol Alergol
. 2018
Feb
;35
(1
):99
–105
.
[PubMed]
1642-395X5.
Foong
RE
, Bosco
A
, Troy
NM
, Gorman
S
, Hart
PH
, Kicic
A
, et al. Identification of genes differentially regulated by vitamin D deficiency that alter lung pathophysiology and inflammation in allergic airways disease
. Am J Physiol Lung Cell Mol Physiol
. 2016
Sep
;311
(3
):L653
–63
.
[PubMed]
1040-06056.
Agrawal
T
, Gupta
GK
, Agrawal
DK
. Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model
. Clin Exp Allergy
. 2013
Jun
;43
(6
):672
–83
.
[PubMed]
1365-22227.
Agrawal
T
, Gupta
GK
, Agrawal
DK
. Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation
. Exp Mol Pathol
. 2012
Aug
;93
(1
):74
–81
.
[PubMed]
0014-48008.
Dimeloe
S
, Nanzer
A
, Ryanna
K
, Hawrylowicz
C
. Regulatory T cells, inflammation and the allergic response-The role of glucocorticoids and Vitamin D
. J Steroid Biochem Mol Biol
. 2010
May
;120
(2-3
):86
–95
.
[PubMed]
0960-07609.
Hall
SC
, Agrawal
DK
. Vitamin D and Bronchial Asthma: An Overview of Data From the Past 5 Years
. Clin Ther
. 2017
May
;39
(5
):917
–29
.
[PubMed]
0149-291810.
Sandhu
MS
, Casale
TB
: The role of vitamin D in asthma.
Ann Allergy Asthma Immunol 2010
;105:191-199; quiz 200-192, 217. 11.
Baroni
E
, Biffi
M
, Benigni
F
, Monno
A
, Carlucci
D
, Carmeliet
G
, et al. VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3
. J Leukoc Biol
. 2007
Jan
;81
(1
):250
–62
.
[PubMed]
0741-540012.
Matheu
V
, Bäck
O
, Mondoc
E
, Issazadeh-Navikas
S
. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease
. J Allergy Clin Immunol
. 2003
Sep
;112
(3
):585
–92
.
[PubMed]
0091-674913.
Pichler
J
, Gerstmayr
M
, Szépfalusi
Z
, Urbanek
R
, Peterlik
M
, Willheim
M
. 1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells
. Pediatr Res
. 2002
Jul
;52
(1
):12
–8
.
[PubMed]
0031-399814.
Adorini
L
, Penna
G
, Giarratana
N
, Roncari
A
, Amuchastegui
S
, Daniel
KC
, et al. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands
. J Steroid Biochem Mol Biol
. 2004
May
;89-90
(1-5
):437
–41
.
[PubMed]
0960-076015.
Hewison
M
, Freeman
L
, Hughes
SV
, Evans
KN
, Bland
R
, Eliopoulos
AG
, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells
. J Immunol
. 2003
Jun
;170
(11
):5382
–90
.
[PubMed]
0022-176716.
Urry
Z
, Xystrakis
E
, Richards
DF
, McDonald
J
, Sattar
Z
, Cousins
DJ
, et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function
. J Clin Invest
. 2009
Feb
;119
(2
):387
–98
.
[PubMed]
0021-973817.
Martineau
AR
, Jolliffe
DA
, Hooper
RL
, Greenberg
L
, Aloia
JF
, Bergman
P
, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
. BMJ
. 2017
Feb
;356
:i6583
.
[PubMed]
0959-813818.
Zdrenghea
MT
, Makrinioti
H
, Bagacean
C
, Bush
A
, Johnston
SL
, Stanciu
LA
. Vitamin D modulation of innate immune responses to respiratory viral infections
. Rev Med Virol
. 2017
Jan
;27
(1
):27
.
[PubMed]
1052-927619.
Toyota
N
, Sakai
H
, Takahashi
H
, Hashimoto
Y
, Iizuka
H
. Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on mast cell proliferation and A23187-induced histamine release, also accompanied by a decreased c-kit receptor
. Arch Dermatol Res
. 1996
Oct
;288
(11
):709
–15
.
[PubMed]
0340-369620.
Chachi
L
, Alzahrani
A
, Koziol-White
C
, Biddle
M
, Bagadood
R
, Panettieri
RA
Jr, et al. Increased β2-adrenoceptor phosphorylation in airway smooth muscle in severe asthma: possible role of mast cell-derived growth factors
. Clin Exp Immunol
. 2018
Nov
;194
(2
):253
–8
.
[PubMed]
0009-910421.
Triggiani
M
, Granata
F
, Giannattasio
G
, Marone
G
. Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes
. J Allergy Clin Immunol
. 2005
Nov
;116
(5
):1000
–6
.
[PubMed]
0091-674922.
Chiba
Y
, Suto
W
, Sakai
H
. Augmented Pla2g4c/Ptgs2/Hpgds axis in bronchial smooth muscle tissues of experimental asthma
. PLoS One
. 2018
Aug
;13
(8
):e0202623
.
[PubMed]
1932-620323.
Hallstrand
TS
, Lai
Y
, Hooper
KA
, Oslund
RC
, Altemeier
WA
, Matute-Bello
G
, Gelb
MH
: Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils. J Allergy Clin Immunol 2016
;137:268-277 e268.24.
Nolin
JD
, Ogden
HL
, Lai
Y
, Altemeier
WA
, Frevert
CW
, Bollinger
JG
, et al. Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma
. Am J Respir Cell Mol Biol
. 2016
Dec
;55
(6
):825
–36
.
[PubMed]
1044-154925.
Sokolowska
M
, Stefanska
J
, Wodz-Naskiewicz
K
, Pawliczak
R
. Cytosolic phospholipase A2 group IVA influence on GM-CSF expression in human lung cells: a pilot study
. Med Sci Monit
. 2010
Sep
;16
(9
):BR300
–6
.
[PubMed]
1643-375026.
Sokolowska
M
, Borowiec
M
, Ptasinska
A
, Cieslak
M
, Shelhamer
JH
, Kowalski
ML
, et al. 85-kDa cytosolic phospholipase A2 group IValpha gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study
. Clin Exp Immunol
. 2007
Oct
;150
(1
):124
–31
.
[PubMed]
0009-910427.
Sokolowska
M
, Stefanska
J
, Wodz-Naskiewicz
K
, Cieslak
M
, Pawliczak
R
. Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites
. J Allergy Clin Immunol
. 2010
Jun
;125
(6
):1393
–5
.
[PubMed]
0091-674928.
Pniewska
E
, Sokolowska
M
, Kupryś-Lipińska
I
, Przybek
M
, Kuna
P
, Pawliczak
R
. The step further to understand the role of cytosolic phospholipase A2 alpha and group X secretory phospholipase A2 in allergic inflammation: pilot study
. BioMed Res Int
. 2014
;2014
:670814
.
[PubMed]
2314-613329.
Sapirstein
A
, Bonventre
JV
. Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts
. Biochim Biophys Acta
. 2000
Oct
;1488
(1-2
):139
–48
.
[PubMed]
0006-300230.
Nakatani
N
, Uozumi
N
, Kume
K
, Murakami
M
, Kudo
I
, Shimizu
T
. Role of cytosolic phospholipase A2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells
. Biochem J
. 2000
Dec
;352
(Pt 2
):311
–7
.
[PubMed]
0264-602131.
Bonventre
JV
, Huang
Z
, Taheri
MR
, O’Leary
E
, Li
E
, Moskowitz
MA
, et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2
. Nature
. 1997
Dec
;390
(6660
):622
–5
.
[PubMed]
0028-083632.
Gorman
S
, Buckley
AG
, Ling
KM
, Berry
LJ
, Fear
VS
, Stick
SM
, et al. Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity
. Physiol Rep
. 2017
Aug
;5
(15
):5
.
[PubMed]
2051-817X33.
Pfeffer
PE
, Hawrylowicz
CM
. Vitamin D in Asthma: Mechanisms of Action and Considerations for Clinical Trials
. Chest
. 2018
May
;153
(5
):1229
–39
.
[PubMed]
0012-369234.
Lai
G
, Wu
C
, Hong
J
, Song
Y
. 1,25-Dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)) attenuates airway remodeling in a murine model of chronic asthma
. J Asthma
. 2013
Mar
;50
(2
):133
–40
.
[PubMed]
0277-090335.
Szeto
FL
, Sun
J
, Kong
J
, Duan
Y
, Liao
A
, Madara
JL
, et al. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts
. J Steroid Biochem Mol Biol
. 2007
Mar
;103
(3-5
):563
–6
.
[PubMed]
0960-076036.
Won
M
, Byun
HS
, Park
KA
, Hur
GM
. Post-translational control of NF-κB signaling by ubiquitination
. Arch Pharm Res
. 2016
Aug
;39
(8
):1075
–84
.
[PubMed]
0253-626937.
Chen
Y
, Zhang
J
, Ge
X
, Du
J
, Deb
DK
, Li
YC
. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein
. J Biol Chem
. 2013
Jul
;288
(27
):19450
–8
.
[PubMed]
0021-925838.
Haddad Kashani
H
, Seyed Hosseini
E
, Nikzad
H
, Soleimani
A
, Soleimani
M
, Tamadon
MR
, et al. The Effects of Vitamin D Supplementation on Signaling Pathway of Inflammation and Oxidative Stress in Diabetic Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial
. Front Pharmacol
. 2018
Feb
;9
:50
.
[PubMed]
1663-981239.
Sun
J
, Kong
J
, Duan
Y
, Szeto
FL
, Liao
A
, Madara
JL
, et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor
. Am J Physiol Endocrinol Metab
. 2006
Aug
;291
(2
):E315
–22
.
[PubMed]
0193-184940.
Song
Y
, Hong
J
, Liu
D
, Lin
Q
, Lai
G
. 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells
. Scand J Immunol
. 2013
Feb
;77
(2
):109
–16
.
[PubMed]
0300-947541.
Chen
S
, Zhu
J
, Chen
G
, Zuo
S
, Zhang
J
, Chen
Z
, et al. 1,25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-α induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signaling pathway
. Biochem Biophys Res Commun
. 2015
May
;460
(3
):873
–8
.
[PubMed]
0006-291X42.
Won
S
, Sayeed
I
, Peterson
BL
, Wali
B
, Kahn
JS
, Stein
DG
. Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kB signaling pathways
. PLoS One
. 2015
Mar
;10
(3
):e0122821
.
[PubMed]
1932-620343.
Li
B
, Baylink
DJ
, Deb
C
, Zannetti
C
, Rajaallah
F
, Xing
W
, et al. 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo
. PLoS One
. 2013
;8
(3
):e58808
.
[PubMed]
1932-620344.
Gorman
S
, Judge
MA
, Burchell
JT
, Turner
DJ
, Hart
PH
. 1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses
. Immunology
. 2010
Jun
;130
(2
):181
–92
.
[PubMed]
0019-280545.
Xystrakis
E
, Kusumakar
S
, Boswell
S
, Peek
E
, Urry
Z
, Richards
DF
, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients
. J Clin Invest
. 2006
Jan
;116
(1
):146
–55
.
[PubMed]
0021-973846.
Searing
DA
, Zhang
Y
, Murphy
JR
, Hauk
PJ
, Goleva
E
, Leung
DY
. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use
. J Allergy Clin Immunol
. 2010
May
;125
(5
):995
–1000
.
[PubMed]
0091-674947.
Sutherland
ER
, Goleva
E
, Jackson
LP
, Stevens
AD
, Leung
DY
. Vitamin D levels, lung function, and steroid response in adult asthma
. Am J Respir Crit Care Med
. 2010
Apr
;181
(7
):699
–704
.
[PubMed]
1073-449X48.
Wu
AC
, Tantisira
K
, Li
L
, Fuhlbrigge
AL
, Weiss
ST
, Litonjua
A
; Childhood Asthma Management Program Research Group
. Effect of vitamin D and inhaled corticosteroid treatment on lung function in children
. Am J Respir Crit Care Med
. 2012
Sep
;186
(6
):508
–13
.
[PubMed]
1073-449X49.
Goleva
E
, Searing
DA
, Jackson
LP
, Richers
BN
, Leung
DY
. Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma
. J Allergy Clin Immunol
. 2012
May
;129
(5
):1243
–51
.
[PubMed]
0091-674950.
Litonjua
AA
. Vitamin D and corticosteroids in asthma: synergy, interaction and potential therapeutic effects
. Expert Rev Respir Med
. 2013
Apr
;7
(2
):101
–4
.
[PubMed]
1747-634851.
Ohtake
F
, Saeki
Y
, Ishido
S
, Kanno
J
, Tanaka
K
. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling
. Mol Cell
. 2016
Oct
;64
(2
):251
–66
.
[PubMed]
1097-276552.
Pniewska
E
, Pawliczak
R
. The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease
. Mediators Inflamm
. 2013
;2013
:793505
.
[PubMed]
0962-935153.
Bowton
DL
, Dmitrienko
AA
, Israel
E
, Zeiher
BG
, Sides
GD
. Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma
. J Asthma
. 2005
Feb
;42
(1
):65
–71
.
[PubMed]
0277-090354.
Lindbom
J
, Ljungman
AG
, Lindahl
M
, Tagesson
C
. Increased gene expression of novel cytosolic and secretory phospholipase A(2) types in human airway epithelial cells induced by tumor necrosis factor-alpha and IFN-gamma
. J Interferon Cytokine Res
. 2002
Sep
;22
(9
):947
–55
.
[PubMed]
1079-990755.
Murakami
M
, Masuda
S
, Kudo
I
. Arachidonate release and prostaglandin production by group IVC phospholipase A2 (cytosolic phospholipase A2gamma)
. Biochem J
. 2003
Jun
;372
(Pt 3
):695
–702
.
[PubMed]
0264-602156.
Shoseyov
D
, Bibi
H
, Offer
S
, Schwob
O
, Krimsky
M
, Kleiman
M
, et al. Treatment of ovalbumin-induced experimental allergic bronchitis in rats by inhaled inhibitor of secretory phospholipase A(2)
. Thorax
. 2005
Sep
;60
(9
):747
–53
.
[PubMed]
0040-637657.
Sylvia
VL
, Schwartz
Z
, Curry
DB
, Chang
Z
, Dean
DD
, Boyan
BD
. 1,25(OH)2D3 regulates protein kinase C activity through two phospholipid-dependent pathways involving phospholipase A2 and phospholipase C in growth zone chondrocytes
. J Bone Miner Res
. 1998
Apr
;13
(4
):559
–69
.
[PubMed]
0884-043158.
Berridge
MJ
. Inositol lipids and cell proliferation
. Biochim Biophys Acta
. 1987
Apr
;907
(1
):33
–45
.
[PubMed]
0006-300259.
Ye
L
, Dickerson
T
, Kaur
H
, Takada
YK
, Fujita
M
, Liu
R
, et al. Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3
. Bioorg Med Chem Lett
. 2013
Jan
;23
(1
):340
–5
.
[PubMed]
0960-894X60.
Chen
D
, Wei
Y
, Li
X
, Epstein
S
, Wolosin
JM
, Asbell
P
. sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised
. Exp Eye Res
. 2009
May
;88
(5
):880
–8
.
[PubMed]
0014-483561.
Pruzanski
W
, Stefanski
E
, Vadas
P
, Ramamurthy
NS
. Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity
. Biochem Pharmacol
. 1997
Jun
;53
(12
):1901
–7
.
[PubMed]
0006-295262.
Guo
Y
, Li
B
, Xu
X
, Wu
R
, Li
W
. sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt
. Cell Physiol Biochem
. 2015
;37
(4
):1345
–54
.
[PubMed]
1015-898763.
Granata
F
, Staiano
RI
, Loffredo
S
, Petraroli
A
, Genovese
A
, Marone
G
, et al. The role of mast cell-derived secreted phospholipases A2 in respiratory allergy
. Biochimie
. 2010
Jun
;92
(6
):588
–93
.
[PubMed]
0300-908464.
Nolin
JD
, Murphy
RC
, Gelb
MH
, Altemeier
WA
, Henderson
WR
Jr, Hallstrand
TS
. Function of secreted phospholipase A2 group-X in asthma and allergic disease
. Biochim Biophys Acta Mol Cell Biol Lipids
. 2019
Jun
;1864
(6
):827
–37
.
[PubMed]
1388-198165.
Hallstrand
TS
, Chi
EY
, Singer
AG
, Gelb
MH
, Henderson
WR
Jr. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness
. Am J Respir Crit Care Med
. 2007
Dec
;176
(11
):1072
–8
.
[PubMed]
1073-449X66.
Nolin
JD
, Lai
Y
, Ogden
HL
, Manicone
AM
, Murphy
RC
, An
D
, et al. Secreted PLA2 group X orchestrates innate and adaptive immune responses to inhaled allergen
. JCI Insight
. 2017
Nov
;2
(21
):2
.
[PubMed]
2379-370867.
Chilton
FH
, Averill
FJ
, Hubbard
WC
, Fonteh
AN
, Triggiani
M
, Liu
MC
. Antigen-induced generation of lyso-phospholipids in human airways
. J Exp Med
. 1996
May
;183
(5
):2235
–45
.
[PubMed]
0022-100768.
Bowton
DL
, Seeds
MC
, Fasano
MB
, Goldsmith
B
, Bass
DA
. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics
. Am J Respir Crit Care Med
. 1997
Feb
;155
(2
):421
–5
.
[PubMed]
1073-449X69.
Doroudi
M
, Schwartz
Z
, Boyan
BD
. Membrane-mediated actions of 1,25-dihydroxy vitamin D3: a review of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulin-dependent protein kinase II
. J Steroid Biochem Mol Biol
. 2015
Mar
;147
:81
–4
.
[PubMed]
0960-076070.
Chen
J
, Olivares-Navarrete
R
, Wang
Y
, Herman
TR
, Boyan
BD
, Schwartz
Z
. Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts
. J Biol Chem
. 2010
Nov
;285
(47
):37041
–50
.
[PubMed]
0021-925871.
Schwartz
Z
, Graham
EJ
, Wang
L
, Lossdörfer
S
, Gay
I
, Johnson-Pais
TL
, et al. Phospholipase A2 activating protein (PLAA) is required for 1alpha,25(OH)2D3 signaling in growth plate chondrocytes
. J Cell Physiol
. 2005
Apr
;203
(1
):54
–70
.
[PubMed]
0021-954172.
Doroudi
M
, Schwartz
Z
, Boyan
BD
. Phospholipase A2 activating protein is required for 1α,25-dihydroxyvitamin D3 dependent rapid activation of protein kinase C via Pdia3
. J Steroid Biochem Mol Biol
. 2012
Oct
;132
(1-2
):48
–56
.
[PubMed]
0960-076073.
Qu
J
, Do
DC
, Zhou
Y
, Luczak
E
, Mitzner
W
, Anderson
ME
, et al. Oxidized CaMKII promotes asthma through the activation of mast cells
. JCI Insight
. 2017
Jan
;2
(1
):e90139
.
[PubMed]
2379-370874.
Zhang
F
, Sha
J
, Wood
TG
, Galindo
CL
, Garner
HR
, Burkart
MF
, et al. Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA)
. Cell Signal
. 2008
May
;20
(5
):844
–61
.
[PubMed]
0898-656875.
Bomalaski
JS
, Baker
DG
, Brophy
L
, Resurreccion
NV
, Spilberg
I
, Muniain
M
, et al. A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids
. J Immunol
. 1989
Jun
;142
(11
):3957
–62
.
[PubMed]
0022-176776.
Papadopoulos
C
, Kirchner
P
, Bug
M
, Grum
D
, Koerver
L
, Schulze
N
, et al. VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy
. EMBO J
. 2017
Jan
;36
(2
):135
–50
.
[PubMed]
0261-418977.
Falik Zaccai
TC
, Savitzki
D
, Zivony-Elboum
Y
, Vilboux
T
, Fitts
EC
, Shoval
Y
, et al. Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy
. Brain
. 2017
Feb
;140
(2
):370
–86
.
[PubMed]
0006-895078.
Martin
SA
, Brash
AR
, Murphy
RC
. The discovery and early structural studies of arachidonic acid
. J Lipid Res
. 2016
Jul
;57
(7
):1126
–32
.
[PubMed]
0022-227579.
Alexopoulos
EC
, Bouros
D
, Dimadi
M
, Serbescu
A
, Bakoyannis
G
, Kokkinis
FP
. Comparative analysis of induced sputum and bronchoalveolar lavage fluid (BALF) profile in asbestos exposed workers
. J Occup Med Toxicol
. 2011
Aug
;6
(1
):23
.
[PubMed]
1745-667380.
Brunnström
Å
, Tryselius
Y
, Feltenmark
S
, Andersson
E
, Leksell
H
, James
A
, et al. On the biosynthesis of 15-HETE and eoxin C4 by human airway epithelial cells
. Prostaglandins Other Lipid Mediat
. 2015
Sep
;121
Pt A
:83
–90
.
[PubMed]
1098-882381.
Li
J
, Rao
J
, Liu
Y
, Cao
Y
, Zhang
Y
, Zhang
Q
, et al. 15-Lipoxygenase promotes chronic hypoxia-induced pulmonary artery inflammation via positive interaction with nuclear factor-κB
. Arterioscler Thromb Vasc Biol
. 2013
May
;33
(5
):971
–9
.
[PubMed]
1079-564282.
Whitehouse
AS
, Khal
J
, Tisdale
MJ
. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway
. Br J Cancer
. 2003
Aug
;89
(4
):737
–45
.
[PubMed]
0007-092083.
Prato
M
, Gallo
V
, Giribaldi
G
, Aldieri
E
, Arese
P
. Role of the NF-κB transcription pathway in the haemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes
. Cell Microbiol
. 2010
Dec
;12
(12
):1780
–91
.
[PubMed]
1462-581484.
Somjen
D
, Katzburg
S
, Knoll
E
, Sharon
O
, Posner
GH
, Stern
N
. Vitamin D analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cells
. J Steroid Biochem Mol Biol
. 2010
Jul
;121
(1-2
):265
–7
.
[PubMed]
0960-076085.
Planagumà
A
, Kazani
S
, Marigowda
G
, Haworth
O
, Mariani
TJ
, Israel
E
, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma
. Am J Respir Crit Care Med
. 2008
Sep
;178
(6
):574
–82
.
[PubMed]
1073-449X86.
Barnig
C
, Levy
BD
. Lipoxin A4: a new direction in asthma therapy?
Expert Rev Clin Immunol
. 2013
Jun
;9
(6
):491
–3
.
[PubMed]
1744-666X87.
Hashimoto
A
, Hayashi
I
, Murakami
Y
, Sato
Y
, Kitasato
H
, Matsushita
R
, et al. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis
. J Rheumatol
. 2007
Nov
;34
(11
):2144
–53
.
[PubMed]
0315-162X88.
Celik
GE
, Erkekol
FO
, Misirligil
Z
, Melli
M
. Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity
. Clin Exp Allergy
. 2007
Oct
;37
(10
):1494
–501
.
[PubMed]
0954-789489.
Huang
YH
, Wang
HM
, Cai
ZY
, Xu
FY
, Zhou
XY
. Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells
. Inflammation
. 2014
Aug
;37
(4
):1084
–90
.
[PubMed]
0360-399790.
Lech
Z
, Chalubinski
M
, Kosinski
S
, Smorawska
E
, Bassin
C
, Akdis
CA
, Grzegorczyk
J
, Kowalski
ML
: Prostaglandin E2 and lipoxin A4 in PBMCs are associated with immune tolerance during venom immunotherapy. J Allergy Clin Immunol 2016
;138:1199-1202 e1192.91.
Machado
FS
, Aliberti
J
. Role of lipoxin in the modulation of immune response during infection
. Int Immunopharmacol
. 2008
Oct
;8
(10
):1316
–9
.
[PubMed]
1567-576992.
Singh
A
, Rahman
T
, Bartiss
R
, Arabshahi
A
, Prasain
J
, Barnes
S
, et al. Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia
. J Leukoc Biol
. 2017
Feb
;101
(2
):531
–42
.
[PubMed]
0741-540093.
Pappas
K
, Papaioannou
AI
, Kostikas
K
, Tzanakis
N
. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma
. Cytokine
. 2013
Dec
;64
(3
):613
–25
.
[PubMed]
1043-466694.
Hu
F
, Liu
XX
, Wang
X
, Alashkar
M
, Zhang
S
, Xu
JT
, et al. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways
. J Dermatol Sci
. 2015
Jun
;78
(3
):181
–8
.
[PubMed]
0923-181195.
Kure
I
, Nishiumi
S
, Nishitani
Y
, Tanoue
T
, Ishida
T
, Mizuno
M
, et al. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation
. J Pharmacol Exp Ther
. 2010
Feb
;332
(2
):541
–8
.
[PubMed]
0022-356596.
Shi
Y
, Pan
H
, Zhang
HZ
, Zhao
XY
, Jin
J
, Wang
HY
. Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κB and PI3K/Akt signaling pathway in mice
. Eur Rev Med Pharmacol Sci
. 2017
Apr
;21
(8
):1850
–9
.
[PubMed]
2284-072997.
Zhu
M
, Tan
Z
, Luo
Z
, Hu
H
, Wu
T
, Fang
S
, et al. Association of the vitamin D metabolism gene GC and CYP27B1 polymorphisms with cancer susceptibility: a meta-analysis and trial sequential analysis
. Biosci Rep
. 2019
Sep
;39
(9
):BSR20190368
.
[PubMed]
0144-846398.
Playford
MP
, Dey
AK
, Zierold
C
, Joshi
AA
, Blocki
F
, Bonelli
F
, et al. Serum active 1,25(OH)2D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasis
. Atherosclerosis
. 2019
Aug
;289
:44
–50
.
[PubMed]
0021-915099.
Krivoy
A
, Onn
R
, Vilner
Y
, Hochman
E
, Weizman
S
, Paz
A
, et al. Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial
. EBioMedicine
. 2017
Dec
;26
:138
–45
.
[PubMed]
2352-3964100.
Abbatemarco
JR
, Fox
RJ
, Li
H
, Ontaneda
D
. Vitamin D and MRI measures in progressive multiple sclerosis
. Mult Scler Relat Disord
. 2019
Aug
;35
:276
–82
.
[PubMed]
2211-0348101.
Foong
RE
, Shaw
NC
, Berry
LJ
, Hart
PH
, Gorman
S
, Zosky
GR
. Vitamin D deficiency causes airway hyperresponsiveness, increases airway smooth muscle mass, and reduces TGF-β expression in the lungs of female BALB/c mice
. Physiol Rep
. 2014
Mar
;2
(3
):e00276
.
[PubMed]
2051-817X102.
Flayer
CH
, Larson
ED
, Haczku
A
. Breaking Steroid Resistance: Effect of Vitamin D on IL-23
. Am J Respir Cell Mol Biol
. 2017
Sep
;57
(3
):267
–9
.
[PubMed]
1044-1549103.
Lilani
MZ
, Elahi
RT
, Ahmed
A
, Alam
MM
, Batool
SS
. Vitamin D supplementation: an innovative way to prevent asthma exacerbation in developing countries?
J Taibah Univ Med Sci
. 2018
Dec
;14
(1
):99
–100
.
[PubMed]
1658-3612104.
Jensen
ME
, Mailhot
G
, Alos
N
, Rousseau
E
, White
JH
, Khamessan
A
, et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial
. Trials
. 2016
Jul
;17
(1
):353
.
[PubMed]
1745-6215105.
Wang
M
, Liu
M
, Wang
C
, Xiao
Y
, An
T
, Zou
M
, et al. Association between vitamin D status and asthma control: A meta-analysis of randomized trials
. Respir Med
. 2019
Apr
;150
:85
–94
.
[PubMed]
0954-6111© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
